ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0077

Mimickers of Immunoglobulin G4-Related Disease

Madiha Ahmad1, Robert Spandorfer2 and Arezou Khosroshahi3, 1Emory University, Decatur, 2Emory University School of Medicine, Atlanta, GA, 3Emory University, Atlanta, GA

Meeting: ACR Convergence 2020

Keywords: IgG4 Related Disease

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster I: Diagnosis and Testing

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Immunoglobulin G4-related disease (IgG4-RD) is a fibro inflammatory condition of unclear etiology. This rare condition can affect any organ system and has protean manifestations mimicking many other diseases. As the knowledge regarding this condition has increased among providers, there has been a tendency to over diagnose IgG4-RD. Therefore, the primary aim of this retrospective study is to identify common mimickers of IgG4-RD in an United States cohort.

Methods: The study design is a retrospective chart review. All patients referred to the IgG4 clinic at Emory University with specific diagnosis of IgG4-RD from August 2013- February 2020 were reviewed and categorized into mimickers versus IgG4-RD. The diagnosis of IgG4-RD and mimickers were made with clinicopathological correlation. Emory University Institutional Review Board approved this study.

Results: From August 2013- February 2020, a total of 198 patients were referred to the Emory IgG4- RD clinic. As outlined in Table 1, 85 or 43% were noted be mimickers of IgG4-RD. We classified the mimickers into infection (2%), neoplastic disease (21%), autoimmune disease (31%), and other (46%). Based on the IgG-RD classification criteria, 93% of these cases met exclusion criteria and only 7% met inclusion criteria, which had mean scores of 3 and ranged from 0-10 (greater than 20 meets criteria).

The neoplastic category included lymphoma (28%), plasma cell dyscrasia (17%), and histiocytosis (Rosai Dorfman, Langerhans’s, Erdheim Chester Disease) (17%). Noteworthy, 75% of the neoplastic diagnoses were made when repeat biopsy was performed either due to clinical suspicion or lack of response to treatment.

Sjogren’s syndrome was the predominant condition mistaken by IgG4-RD in the autoimmune category. We included cases that could not be proven to be IgG4-RD or any other specific diagnosis in the other category. Interestingly, in that category 60% had a GI manifestation, with half of those cases being recurrent pancreatitis as shown in Table 4.

The average serum IgG4 level across all mimickers was normal, but the levels ranged from 5-4,060 mg/dL (normal range 1-123 mg/dL). We identified 20 cases with elevated serum IgG4. Based on the IgG-RD classification criteria, these patients met exclusion criteria with 9 cases meeting pathologic criteria, 7 radiologic, 2 serologic, and 2 disease specific exclusions. Of note, 8 of these 20 cases had neoplastic disease and 4 cases had recurrent pancreatitis.

Conclusion: This study highlights that almost half of the patients referred for diagnosis of IgG4-RD actually were found to have a mimic of the disease. GI manifestations, particularly recurrent pancreatitis, were among the most common referred diagnosis in our center. It should be emphasized that serum IgG4 levels are not diagnostic for the disease and can be elevated in other conditions. A tissue biopsy is indicated in majority of cases with atypical clinical presentation and repeating the biopsy is indicated if the patient’s course is not typical for IgG4-RD. Also, a lymph node biopsy is not considered diagnostic. By identifying these mimickers, we hope to emphasize the necessity of considering these conditions while evaluating patients with IgG4-RD.

Table 1: Categories of Mimickers

Table 2: Subcategories of Mimickers


Disclosure: M. Ahmad, None; R. Spandorfer, None; A. Khosroshahi, None.

To cite this abstract in AMA style:

Ahmad M, Spandorfer R, Khosroshahi A. Mimickers of Immunoglobulin G4-Related Disease [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/mimickers-of-immunoglobulin-g4-related-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mimickers-of-immunoglobulin-g4-related-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology